trending Market Intelligence /marketintelligence/en/news-insights/trending/iMVQrYX4oy2IqIlKTcF2RQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Kurma Partners seeks €150M for biotechnology fund

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Banking Essentials Newsletter: May Edition

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Kurma Partners seeks €150M for biotechnology fund

Paris-based venture capital firm Kurma Partners, which backs early-stage life sciences companies in Europe, held a first close for Kurma Biofund III.

The fund has a final closing target of €150 million. It will invest in about 12 to 15 private companies, four to five of which will be established by Kurma.

Pharmaceutical company Servier, French national investment bank Bpifrance SA and European midmarket private equity and venture capital firm Idinvest Partners SA, as cornerstone investors, will join the fund's advisory committee. Other institutional investors and family offices also participated in the fund's first closing.